aspsirna0273 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0273
siRNA Name: LRRK2 P4_11C
Gene:Leucine rich repeat kinase 2 (LRRK2) Gene
Disease:Parkinsons disease (PD)
Wild allele/target (5'->3'): GAGAUUGCUGACUACGGCA
Mutant allele/target (5'->3'):GAGAUUGCGGACUACAGCA
Target Mutation: c.6055G>A,p.Gly2019Ser
Wild siRNA (As strand):CUCUAACGACUGAUGCCGU
ASP-siRNA (As strand):CUCUAACGCCUGAUGUCGU
Mismatch position in siRNA: U4C, C11A
Mutant allele (5'->3'): GAGAUUGCGGACUACAGCA
ASP-siRNA (As strand):CUCUAACGCCUGAUGUCGU
ASP-siRNA efficacy for mutant allele:55
Wild allele (5'->3'): GAGAUUGCUGACUACGGCA
ASP-siRNA (As strand):CUCUAACGCCUGAUGUCGU
ASP-siRNA efficacy for wild allele:30
Percentage discrimination for ASP-siRNA:25
Wild allele (5'->3'): GAGAUUGCUGACUACGGCA
Wild siRNA (As strand):CUCUAACGACUGAUGCCGU
Wild sirna efficacy for wild allele:High efficacy
Wild allele (5'->3'): GAGAUUGCUGACUACGGCA
ASP-siRNA (As strand):CUCUAACGCCUGAUGUCGU
Wild sirna efficacy for mutant allele:Moderate efficacy
Percentage discrimination for wild siRNA:Poor discrimination
Concentration:50nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: Q5S007
Target sequence: UUGCAAAGAUUGCUGACUACGGCAUUGCUCAGUACUGC
Genbank Accesion: NM_198578.3
Cell-line: HEK293
Experimental technique used: Flourescence microscopy
Transfection method: Lipofectamine 2000
siRNA expression method: Sigma Genosys
Post-transfection duration: 48 hours
OMID ID: 168600
KEGG disease ID:H00057
Reference:22031823

.
.
.
.
.
.
.
.
.
.
.

.

.

.